ClinicalTrials.Veeva

Menu

The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

National Institute of Allergy and Infectious Diseases (NIAID) logo

National Institute of Allergy and Infectious Diseases (NIAID)

Status

Withdrawn

Conditions

HIV Infections

Treatments

Drug: Oral Vitamin C

Study type

Interventional

Funder types

NIH

Identifiers

NCT00001070
DATRI 017

Details and patient eligibility

About

This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Not applicable - Study withdrawn since 04/23/1996

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems